India’s First Genomics-Based Infectious Diseases Test in Kerala

IIT Bombay-based HaystackAnalytics in collaboration with NIMS Medicity at Neyyattinkara introduced ‘infexnTM’ the genomics test for diagnosing infectious diseases
HaystackAnalytics is a pioneer in genomics-based diagnostics solutions from IIT Bombay and NIMS Medicity. (Representational image: Unsplash)
HaystackAnalytics is a pioneer in genomics-based diagnostics solutions from IIT Bombay and NIMS Medicity. (Representational image: Unsplash)
Published on

IIT Bombay-based company HaystackAnalytics in collaboration with NIMS Medicity at Neyyattinkara, Kerala introduced ‘infexnTM’, a genomic test for diagnosing infectious diseases, according to a statement issued on Thursday.

HaystackAnalytics is a pioneer in genomics-based diagnostics solutions from IIT Bombay and NIMS Medicity. A private super specialty hospital in Kerala joined their hands to bring up the world’s first on-site genomics test for infectious disease diagnostic in the city.

According to the joint statement given by the two entities, this partnership represents a significant breakthrough in the field of medicine aimed at detecting infectious diseases in Kerala. This initiative marks a key moment in the city’s diagnostic landscape, promising immaculate results and competent services by equipping the diagnostic center with genome sequencing technology to tackle infectious diseases effectively.

HaystackAnalytics is a pioneer in genomics-based diagnostics solutions from IIT Bombay and NIMS Medicity. (Representational image: Unsplash)
Researchers Leverage AI to Develop Early Diagnostic Test for Ovarian Cancer

The ‘infexnTM’ is a state-of-the-art targeted next-generation sequencing test designed to detect any bacterial or fungal infection along with the detection of relevant antimicrobial resistance genes within 24 hours. Made in India, infexnTM is a go-to test for infectious detection. The test is a kit cum software solution and can be performed within a hospital. The ‘infexn’ report can be life-saving for patients with suspected ailments.

The statement also said that, more importantly, it can empower the healthcare ecosystem with advanced definitive diagnostics to achieve tailored antibiotic usage. This path-breaking initiative will also enable the effective implementation of the national goal of championing antimicrobial stewardship which aligns with India's commitment towards the fight against antimicrobial resistance in the G20 presidency.

The ‘infexnTM’ is a state-of-the-art targeted next-generation sequencing test designed to detect any bacterial or fungal infection along with the detection of relevant antimicrobial resistance genes within 24 hours. ( Representational image: Unsplash)
The ‘infexnTM’ is a state-of-the-art targeted next-generation sequencing test designed to detect any bacterial or fungal infection along with the detection of relevant antimicrobial resistance genes within 24 hours. ( Representational image: Unsplash)

Dr. Aneesh Nair, Principal Scientist and head of the NIMS Centre for Genomic Medicine, remarked on the launch and said that this innovative approach promises to enhance the accuracy and efficiency of infectious disease detection, marking a significant milestone in the healthcare sector. He also said that their collaboration with HaystackAnalytics reflects the efforts to bring innovation and advanced technologies to the doorstep of Kerala.

The Director of Medical Affairs (Infectious diseases), HaystackAnalytics, Dr. Manual Dasgupta Kapoor, was cited as saying that this state-of-the-art genomic testing solution brings to the clinicians efficient and accurate diagnosis of infectious diseases, leading to targeted therapy and improved patient outcomes. She also said that they were excited to lead the way in this innovative journey of making genome sequencing-based diagnostic solutions accurate, applicable, and accessible to the masses.

(Input from various sources)       

(Rehash/Lavanya Beeraboina)

HaystackAnalytics is a pioneer in genomics-based diagnostics solutions from IIT Bombay and NIMS Medicity. (Representational image: Unsplash)
Experimental Gene Therapy Allows Kids With Inherited Deafness to Hear
logo
Medbound
www.medboundtimes.com